The project's objective is to understand the molecular regulatory processes cells use to minimize genetic damage and genetic instability associated with reactive oxygen species (ROS) arising from endogenous processes or ionizing radiation (IR). This goal is addressed through studies of FANCG/XRCC9, the gene that is defective in. group G of the cancer-prone disorder Fanconi anemia (FA). Because FancG protein confers IR resistance in hamster cells, the human homolog is expected to participate in IR responses in human cells. Historically, a link between the FA genes and radiation responses has been unclear, with some studies suggesting that the primary defect in FA lies in removing DNA interstrand crosslinks. The general hypothesis to be tested is that the FANCG protein, as a member of a multiprotein complex, protects mammalian cells against endogenous and IR-generated oxidative damage and maintains genomic integrity by coordinating homeostasis processes that include regulation of ROS levels, apoptosis, and cell cycle progression. The proposed studies will provide a highly quantitative characterization of FANCG protein's contribution to biochemical and cellular endpoints associated with both normal cell proliferation and responses to IR exposure. Isogenic pairs of mutant and FANCG-complemented cells will be derived in both hamster CHO cells and human lymphoblasts. These pairs will be analyzed with respect to chromosomal aberrations, cell survival, hprt gene mutations, apoptosis, ROS, and cell cycle parameters with and without IR exposure. The FANCG-complemented FA-G lymphoblasts will be used to examine gene and protein regulation during the cell cycle as well as the subcellular localization of the protein with and without IR damage. Three proteins that are candidate interactors with FANCG from preliminary studies will be evaluated for possible involvement in the FA pathway. Finally, already identified high-frequency human allelic variants of FANCG in the US population will be evaluated for degree of dysfunction. The results of these studies will lead to more specific models of the nature of the FA protein """"""""pathway"""""""" and its quantitative contributions to multiple biological effects associated with IR-mediated oxidative damage.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA089405-04
Application #
6690016
Study Section
Radiation Study Section (RAD)
Program Officer
Pelroy, Richard
Project Start
2001-01-24
Project End
2005-12-31
Budget Start
2004-01-01
Budget End
2005-12-31
Support Year
4
Fiscal Year
2004
Total Cost
$364,734
Indirect Cost
Name
Lawrence Livermore National Laboratory
Department
Biology
Type
Organized Research Units
DUNS #
827171463
City
Livermore
State
CA
Country
United States
Zip Code
94550
Rybanska, Ivana; Gursky, Jan; Faskova, Miriam et al. (2010) Newly identified CHO ERCC3/XPB mutations and phenotype characterization. Mutagenesis 25:179-85
Hinz, John M; Nham, Peter B; Urbin, Salustra S et al. (2007) Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res 35:3733-40
Savery, Laura C; Grlickova-Duzevik, Eliza; Wise, Sandra S et al. (2007) Role of the Fancg gene in protecting cells from particulate chromate-induced chromosome instability. Mutat Res 626:120-7
Hinz, John M; Nham, Peter B; Yamada, N Alice et al. (2006) Four human FANCG polymorphic variants show normal biological function in hamster CHO cells. Mutat Res 602:34-42
Hussain, Shobbir; Wilson, James B; Blom, Eric et al. (2006) Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair (Amst) 5:629-40
Hinz, John M; Tebbs, Robert S; Wilson, Paul F et al. (2006) Repression of mutagenesis by Rad51D-mediated homologous recombination. Nucleic Acids Res 34:1358-68
Hinz, John M; Nham, Peter B; Salazar, Edmund P et al. (2006) The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair (Amst) 5:875-84
Wiese, Claudia; Hinz, John M; Tebbs, Robert S et al. (2006) Disparate requirements for the Walker A and B ATPase motifs of human RAD51D in homologous recombination. Nucleic Acids Res 34:2833-43
Tebbs, Robert S; Hinz, John M; Yamada, N Alice et al. (2005) New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair (Amst) 4:11-22
Yamamoto, Kazuhiko; Hirano, Seiki; Ishiai, Masamichi et al. (2005) Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. Mol Cell Biol 25:34-43

Showing the most recent 10 out of 14 publications